Six research groups from Cleveland Clinic and Case Western Reserve University will participate in the second phase of the Armed Forces Institute of Regenerative Medicine program called AFIRM-II, which is being funded by the Department of Defense. The teams will conduct clinical trials on cutting-edge treatments including tissue regeneration and transplantation that could be used to heal wounded military members.

Related Summaries